Detection of Candida auris by polymerase chain reaction (PCR) will provide faster results to aid healthcare providers in their efforts to combat spread of the infectious fungus. |
May 1, 2023 |
New ARUP Test Will Aid Surveillance for Emerging Outbreaks of Candida auris ARUP’s new test to detect Candida auris will offer a robust screening tool to help clinical facilities identify patients colonized with the yeast and guide infection prevention measures. |
Members of the Biochemical Genetics laboratory gather for a photo. |
April 27, 2023 | ARUP’s Biochemical Genetics lab performs critical, complex testing to diagnose and monitor metabolic disorders. Every person in the laboratory plays a role in promptly delivering thorough results. |
April 24, 2023 |
Start Lab Week 2023 with Five Pieces Focused on the Value Labs Bring to Patient Care We are kickstarting Lab Week by putting a spotlight on the important role that medical laboratory professionals have in improving and saving patient lives. |
|
April 19, 2023 |
Increased Incidence of Babesiosis Leads to Endemic Levels in 3 More States Tickborne diseases such as babesiosis are on the rise in the United States and are primarily transmitted during the summer months when ticks are most active. |
|
ARUP Chief Medical Officer Jonathan Genzen, MD, PhD (left), Director of Healthcare Advisory Services Sandy Richman, MBA, C(ASCP) (middle), and Digital Pathology Project Manager Sumie Edwards, MLS(ASCP)CM (right), will join industry leaders at the 2023 Executive War College conference April 25–27 to offer guidance on laboratory management and operations. |
April 18, 2023 |
ARUP Experts to Share Insights on Laboratory Management at 2023 Executive War College Conference Jonathan Genzen, MD, PhD, Sandy Richman, MBA, C(ASCP), and Sumie Edwards, MLS(ASCP)CM, will join leaders at the Executive War College conference April 25–27 to offer guidance on lab management. |
April 12, 2023 |
ARUP Laboratories Chooses Gestalt’s PathFlow Solution for Its Strategic Digital Initiatives ARUP and Gestalt Diagnostics announced a partnership under which ARUP will adopt Gestalt’s PathFlow® platform as a foundation for future digital pathology initiatives. |